{"count": 1, "results": [{"_id": "37738652", "pmid": 37738652, "title": "EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B cell lymphoma.", "journal": "Blood", "authors": ["Liu Y", "Kimpara S", "Hoang NM", "Daenthanasanmak A", "Li Y", "Lu L", "Ngo VN", "Bates P", "Song L", "Gao X", "Bebel S", "Chen M", "Chen R", "Zhang X", "Selberg PE", "Kenkre VP", "Capitini CM", "Waldmann T", "Rui L"], "date": "2023-09-22T00:00:00Z", "doi": "10.1182/blood.2023020142", "meta_date_publication": "2023 Sep 22", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50251.402, "text_hl": "These findings suggest that targeting @GENE_EGR1 @GENE_1958 @@@EGR1@@@-mediated metabolic reprogramming to OXPHOS with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or IM156 provides a potential therapeutic strategy to overcome @CHEMICAL_ibrutinib @CHEMICAL_MESH:C551803 @@@ibrutinib@@@ resistance in relapsed/refractory @DISEASE_Lymphoma_Large_B_Cell_Diffuse @DISEASE_MESH:D016403 @@@DLBCL@@@ or @<m>DISEASE_Lymphoma_Mantle_Cell</m> @DISEASE_MESH:D020522 @@@MCL@@@.", "citations": {"NLM": "Liu Y, Kimpara S, Hoang NM, Daenthanasanmak A, Li Y, Lu L, Ngo VN, Bates P, Song L, Gao X, Bebel S, Chen M, Chen R, Zhang X, Selberg PE, Kenkre VP, Capitini CM, Waldmann T, Rui L. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B cell lymphoma. Blood. 2023 Sep 22;():. PMID: 37738652", "BibTeX": "@article{37738652, title={EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B cell lymphoma.}, author={Liu Y and Kimpara S and Hoang NM and Daenthanasanmak A and Li Y and Lu L and Ngo VN and Bates P and Song L and Gao X and Bebel S and Chen M and Chen R and Zhang X and Selberg PE and Kenkre VP and Capitini CM and Waldmann T and Rui L}, journal={Blood}}"}}]}